Sällsynta mutationer leder till framtidens behandling
2009 (Swedish)In: Läkartidningen, ISSN 0023-7205, Vol. 106, no 20, 1396-1400 p.Article in journal (Refereed) Published
The identification of disease-causing mutations in Alzheimer’s disease has greatly contributed to our understanding of the pathogenesis. Based on this knowledge, a number of therapeutic strategies are under development, most of which are aimed at lowering the amount of Abpeptides in the affected brain. Due to intense research efforts and massive investments at universities and in the pharmaceutical industry, the future perspectives for Alzheimer patients have never looked brighter.
Place, publisher, year, edition, pages
2009. Vol. 106, no 20, 1396-1400 p.
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:uu:diva-123164PubMedID: 19585838OAI: oai:DiVA.org:uu-123164DiVA: diva2:312536